A Phase I Clinical Trial to Evaluate the Bioequivalence of an Adalimumab Biosimilar Adalimumab-WIBP and Humira®

Shengling Hu, Yang Liu, Lu Yang,Yunkai Yang, Feiguang Long, Hongying Bao, Huijun Zhang, Xin Yue,Jiayou Zhang,Zejun Wang,Chaolin Huang, Jingli Wang, Liu Xia,Yongbing Pan,Yuntao Zhang,Fengyun Gong

CLINICAL DRUG INVESTIGATION（2024）

Cited 0|Views3

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined